Mitoxantrone Active Not Recruiting Phase 1 Trials for Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01830777Brentuximab Vedotin + Re-induction Chemotherapy for AML
NCT03563560A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia